J C Levy1. Show Affiliations » 1. Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, UK.
Abstract
Entities: Disease Gene
Mesh： See more » Administration, OralDiabetes Mellitus, Type 2/drug therapyDiabetes Mellitus, Type 2/physiopathologyDiabetic Angiopathies/prevention & controlDipeptidyl Peptidase 4/physiologyEnzyme Inhibitors/therapeutic useGlucagon-Like Peptide 1/physiologyGlucagon-Like Peptide-1 ReceptorHumansHypoglycemic Agents/administration & dosageHypoglycemic Agents/therapeutic useInjections, SubcutaneousReceptors, Glucagon/agonistsWeight Loss/drug effects
Substances： See more » Enzyme InhibitorsGLP1R protein, humanGlucagon-Like Peptide-1 ReceptorHypoglycemic AgentsReceptors, GlucagonGlucagon-Like Peptide 1Dipeptidyl Peptidase 4
Year: 2006 PMID： 16483260 DOI： 10.1111/j.1464-5491.2006.01833e.x
Source DB: PubMed Journal: Diabet Med ISSN： 0742-3071 Impact factor: 4.359